The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 80, 219-230
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiationInternational Immunology, 2011
- GATA Transcription Factors and CancerGenes & Cancer, 2010
- Higher levels of GATA3 predict better survival in women with breast cancerHuman Pathology, 2010
- GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2010
- The Importance of Identifying and Validating Prognostic Factors in OncologySeminars in Oncology, 2010
- Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursBreast Cancer Research, 2009
- Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factorNeuroscience Letters, 2008
- Cyclic Regulation of T-Bet and GATA-3 in Human EndometriumReproductive Sciences, 2008
- Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate CancerJournal of Clinical Oncology, 2006
- Associations between gene expressions in breast cancer and patient survivalHuman Genetics, 2002